2023 - Research.com Medicine in United States Leader Award
2023 - Research.com Biology and Biochemistry in United States Leader Award
2022 - Research.com Best Scientist Award
2022 - Research.com Biology and Biochemistry in United States Leader Award
2019 - Fellow of the American Academy of Arts and Sciences
2016 - Member of the National Academy of Sciences
2015 - Fellow, National Academy of Inventors
2015 - Member of the National Academy of Medicine (NAM)
Kenneth W. Kinzler mostly deals with Genetics, Cancer research, Mutation, Gene and Carcinogenesis. Kenneth W. Kinzler has included themes like Phenotype, Mutant, Tumor suppressor gene and Colorectal cancer, Adenomatous polyposis coli in his Cancer research study. His Mutation research is multidisciplinary, incorporating perspectives in Telomere and Gene targeting.
His Gene study integrates concerns from other disciplines, such as Molecular biology and PI3K/AKT/mTOR pathway. His research investigates the connection between Carcinogenesis and topics such as Gene expression that intersect with problems in Gene duplication. His Cancer research incorporates elements of Disease and Oncology.
His primary areas of study are Cancer research, Genetics, Gene, Cancer and Molecular biology. His research integrates issues of Carcinogenesis, Tumor suppressor gene, Immunology and Colorectal cancer, Adenomatous polyposis coli in his study of Cancer research. The concepts of his Colorectal cancer study are interwoven with issues in Metastasis and Oncology.
His Mutation, DNA mismatch repair, Germline mutation, Human genome and Genome investigations are all subjects of Genetics research. His study looks at the relationship between Cancer and fields such as Pathology, as well as how they intersect with chemical problems. His Molecular biology research includes elements of Mutant and DNA.
His scientific interests lie mostly in Internal medicine, Cancer, Oncology, Cancer research and Pathology. Cancer is a subfield of Genetics that Kenneth W. Kinzler studies. His Oncology research is multidisciplinary, relying on both Colorectal cancer, Circulating tumor DNA, Disease and Minimal residual disease.
Kenneth W. Kinzler combines subjects such as Mutation, T cell, Blockade, Oncogene and DNA mismatch repair with his study of Cancer research. His Pathology research incorporates themes from Bladder cancer, KRAS and CDKN2A. His study with Carcinogenesis involves better knowledge in Gene.
Kenneth W. Kinzler mainly investigates Cancer, Cancer research, Pathology, Mutation and Internal medicine. His Cancer study is related to the wider topic of Genetics. His biological study spans a wide range of topics, including Somatic cell, T cell, Blockade and Colorectal cancer, DNA mismatch repair.
His Pathology research is multidisciplinary, incorporating elements of Bladder cancer, Cystectomy, KRAS and Urinary bladder. He has researched Mutation in several fields, including Regulation of gene expression, Signal transduction, Glutamine, Telomerase reverse transcriptase and Citric acid cycle. In his study, Carcinoembryonic antigen, Chemotherapy regimen, Irinotecan and Oxaliplatin is strongly linked to Oncology, which falls under the umbrella field of Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
WAF1, a potential mediator of p53 tumor suppression
Wafik S. El-Deiry;Takashi Tokino;Victor E. Velculescu;Daniel B. Levy.
Cell (1993)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Dung T. Le;Jennifer N. Uram;Hao Wang;Bjarne R. Bartlett.
The New England Journal of Medicine (2015)
Cancer Genome Landscapes
Bert Vogelstein;Nickolas Papadopoulos;Victor E. Velculescu;Shibin Zhou.
Science (2013)
Lessons from Hereditary Colorectal Cancer
Kenneth W Kinzler;Bert Vogelstein;Bert Vogelstein.
Cell (1996)
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
D. Williams Parsons;Siân Jones;Xiaosong Zhang;Jimmy Cheng-Ho Lin.
Science (2008)
Serial analysis of gene expression
Kenneth W Kinzler;Victor E Velvulescu;Bert Vogelstein;Lin Zhang.
Science (2000)
Identification of c-MYC as a Target of the APC Pathway
Tong Chuan He;Andrew B. Sparks;Carlo Rago;Heiko Hermeking.
Science (1998)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan;D. Williams Parsons;Genglin Jin;Roger McLendon.
The New England Journal of Medicine (2009)
Cancer genes and the pathways they control.
Bert Vogelstein;Kenneth W Kinzler.
Nature Medicine (2004)
Genetic instabilities in human cancers
Christoph Lengauer;Kenneth W. Kinzler;Bert Vogelstein.
Nature (1998)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Johns Hopkins University
Johns Hopkins University School of Medicine
Johns Hopkins University School of Medicine
Memorial Sloan Kettering Cancer Center
Johns Hopkins University School of Medicine
The University of Texas MD Anderson Cancer Center
Case Western Reserve University
Johns Hopkins University
Harvard University
The University of Texas at Dallas
City College of New York
Roma Tre University
Curtin University
University of Ferrara
Kyoto Prefectural University
University of Brescia
University of Melbourne
University of Toronto
Tohoku University
Stockholm University
National Oceanography Centre
Karolinska Institute
Indiana University
University of Oxford
Medical University of Vienna
Augusta University